Receptor News and Research

RSS

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

The ongoing COVID-19 pandemic caused by SARS-CoV-2 has caused serious damage to public health and the global economy, and one strategy to combat COVID-19 has been the development of broadly neutralizing antibodies for prophylactic and therapeutic use.

1 Mar 2024

Unlocking the molecular mysteries of autism and intellectual disability

A new study from a team of McGill University and Vanderbilt University researchers is shedding light on our understanding of the molecular origins of some forms of autism and intellectual disability.

1 Mar 2024

Does vitamin D have protective role against COVID-19?

Whether vitamin D supplementation before the onset of COVID-19 could provide benefits.

1 Mar 2024

COVID-19's lasting mark: Long-term smell and taste loss

Study reveals prolonged olfactory and gustatory dysfunction in some COVID-19 recoverees, highlighting a need for better clinical support and understanding of long-term effects.

29 Feb 2024

UC Riverside professor receives NIH grant for neurodevelopmental disorder study

Iryna Ethell, a professor of biomedical sciences in the School of Medicine at the University of California, Riverside, has been awarded a five-year grant of $2.4 million from the National Institutes of Health to study mechanisms of hyperexcitability and seizures in neurodevelopmental disorders such as such as attention-deficit/hyperactivity disorder and autism.

29 Feb 2024

Breakthrough gene silencing method slashes cholesterol for a year in mice, no DNA damage

Researchers developed an engineered transcriptional repressor that durably silences the Pcsk9 gene in mice, reducing cholesterol levels for up to a year with a single treatment, showcasing a potential breakthrough in genetic disorder treatments without the risks of DNA mutation.

29 Feb 2024

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

Researchers compare the extent of weight loss after one-year termination of active intervention with GLP-1 receptor agonist, exercise, or combination.

29 Feb 2024

UB research may offer a more streamlined approach to developing cancer drugs

Drug discovery can be a frustrating process of trial and error.

28 Feb 2024

Study: Potential biomarker in the blood predicts sudden cardiac deaths

The discovery of a biomarker readily measured in blood could be a significant step towards preventing sudden deaths.

28 Feb 2024

How can food influence the severity of menopausal hot flashes?

Mechanisms and nutrients related to menopause hot flashes.

28 Feb 2024

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Research identifies the human transferrin receptor as an alternative pathway for SARS-CoV-2 infection, offering potential new targets for COVID-19 therapies.

27 Feb 2024

Resistant starch diet proves a game changer for weight loss and diabetes control

Supplementation with resistant starch leads to weight loss and improved insulin sensitivity by altering the gut microbiome and increasing secondary bile acids, according to a recent study in Nature Metabolism.

27 Feb 2024

Discovery of bicarbonate-sensing receptor offers therapeutic insights into ischemic stroke treatment

Researchers have identified this receptor in brain mural cells that regulates reperfusion injury.

27 Feb 2024

Study uncovers the anti-aging role of vitamin D and vitamin D receptor in Drosophila midgut model

A new research paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 16, Issue 3, entitled, "The anti-aging effect of vitamin D and vitamin D receptor in Drosophila midgut."

27 Feb 2024

Mapping the brain: How cell types and location influence Parkinson’s disease

A single-cell spatial transcriptome analysis on murine brain expression in age and disease using a Parkinson's disease.

27 Feb 2024

Vaping increases susceptibility to COVID-19 infection, study finds

Vapers are susceptible to infection by SARS-CoV-2, the virus that spreads COVID-19 and continues to infect people around the world, a University of California, Riverside, study has found.

26 Feb 2024

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Boston College Assistant Professor of Biology Emrah Altindis has been awarded a five-year, $2.5-million grant from the National Institutes of Health to study viral insulins and mechanisms related to IGF-1 receptor protein inhibition and its potential applications in cancer treatment.

26 Feb 2024

Receptor News and Research

Broad-spectrum neutralizing antibody mAb-39 targets conserved S2 epitope in SARS-CoV-2

Unlocking the molecular mysteries of autism and intellectual disability

Does vitamin D have protective role against COVID-19?

COVID-19's lasting mark: Long-term smell and taste loss

UC Riverside professor receives NIH grant for neurodevelopmental disorder study

Breakthrough gene silencing method slashes cholesterol for a year in mice, no DNA damage

Exercise, GLP-1 receptor agonist, or combined approach explored in year-long study

UB research may offer a more streamlined approach to developing cancer drugs

Study: Potential biomarker in the blood predicts sudden cardiac deaths

How can food influence the severity of menopausal hot flashes?

Scientists uncover a new doorway for SARS-CoV-2 into human cells

Resistant starch diet proves a game changer for weight loss and diabetes control

Discovery of bicarbonate-sensing receptor offers therapeutic insights into ischemic stroke treatment

Study uncovers the anti-aging role of vitamin D and vitamin D receptor in Drosophila midgut model

Mapping the brain: How cell types and location influence Parkinson’s disease

Vaping increases susceptibility to COVID-19 infection, study finds

Boston College biologist wins NIH grant to study viral insulins for cancer treatment

Novel insights into pathologies of diabetic cardiomyopathy, hippocampal neurotoxicity, and Alzheimer’s

Study: Antibody combination shows safety and anti-tumor activity in advanced cancer patients

Novel approach uses patient's cells as "trojan horse" to target lung cancer cells

Achieving and maintaining ISO 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Latest News